Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition. Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
